Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P Futures
6,039.75
+1.50(+0.02%)
Dow Futures
44,991.00
+40.00(+0.09%)
Nasdaq Futures
20,983.00
-10.50(-0.05%)
Russell 2000 Futures
2,436.20
+3.80(+0.16%)
Crude Oil
68.67
-0.10(-0.15%)
Gold
2,638.20
+16.90(+0.64%)

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

24.35

-0.53

(-2.13%)

At close: 04:00PM EST

24.35

0.00

(0.00%)

After hours:

04:20PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.22B
Enterprise Value	923.87M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	4.21
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-6.28

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	109.25%
S&P500 52-Week Change ³	31.57%
52 Week High ³	30.03
52 Week Low ³	9.80
50-Day Moving Average ³	26.58
200-Day Moving Average ³	22.16

Share Statistics

Avg Vol (3 month) ³	258.56k
Avg Vol (10 day) ³	237.17k
Shares Outstanding ⁵	48.86M
Implied Shares Outstanding ⁶	48.86M
Float ⁸	25.52k
% Held by Insiders ¹	6.39%
% Held by Institutions ¹	98.75%
Shares Short (Nov 15, 2024) ⁴	7.07M
Short Ratio (Nov 15, 2024) ⁴	29.73
Short % of Float (Nov 15, 2024) ⁴	34.11%
Short % of Shares Outstanding (Nov 15, 2024) ⁴	14.46%
Shares Short (prior month Oct 15, 2024) ⁴	6.51M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-21.37%
Return on Equity (ttm)	-30.98%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-98.78M
Net Income Avi to Common (ttm)	-85.21M
Diluted EPS (ttm)	-1.89
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	291.83M
Total Cash Per Share (mrq)	6,046.24
Total Debt (mrq)	N/A
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	17.44
Book Value Per Share (mrq)	5,975.16

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A